Lindberg A
Infektionskliniken, Länssjukhuset, Halmstad.
Nord Med. 1990;105(10):261, 265.
In contrast to the other Nordic countries Sweden has long had a favourable position as regards meningococcal disease. In the last 10 year period the annual incidence has been only about one case per 100,000 inhabitants. The treatment once the cause is confirmed is conventional and no different from that in the other Nordic countries but varies somewhat in the event of unknown etiology. Cortisone therapy also seems to be more frequent in treatment of meningitis. Two strategies for antibiotic prophylaxis are used in Sweden.
与其他北欧国家相比，瑞典在脑膜炎球菌病方面长期处于有利地位。在过去10年里，年发病率仅为每10万居民约1例。一旦病因得到确认，治疗方法是常规的，与其他北欧国家没有区别，但在病因不明的情况下会有所不同。在脑膜炎治疗中，皮质类固醇疗法似乎也更常用。瑞典采用两种抗生素预防策略。
